2006
DOI: 10.1016/j.jaapos.2006.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Ocular complications of autoimmune polyendocrinopathy syndrome type 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
13
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(14 citation statements)
references
References 23 publications
0
13
0
Order By: Relevance
“…Retinal pigment degeneration was presented in 3 of 46 patients. The most frequent ocular complication in APS-1 is chronic keratitis or keratinonjunctivitis presenting in 20–35% of patients with peak of the manifestation at the age of 10–15 [3,7,20,21]. Retinal detachment was described in APS-1 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Retinal pigment degeneration was presented in 3 of 46 patients. The most frequent ocular complication in APS-1 is chronic keratitis or keratinonjunctivitis presenting in 20–35% of patients with peak of the manifestation at the age of 10–15 [3,7,20,21]. Retinal detachment was described in APS-1 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Topical steroids and cyclosporine A may be helpful for treatment of keratitis, but many patients on such therapy develop irreversible corneal scarring. 72 A new cyclosporine A prodrug, which may be used topically, improves bioavailability. Rituximab has been reported to have beneficial effects on pneumonitis and malabsorption, 73 while cyclosporine A has improved pancreatic insufficiency.…”
Section: Treatment and Follow-up Of Autoimmune Polyendocrine Syndromesmentioning
confidence: 99%
“…Importantly, Sjögren’s Syndrome has also been described in a subset of patients with APS1 (16). In addition, keratoconjunctivitis sicca (KCS), a clinical hallmark of Sjögren’s Syndrome, has been described in a recent study of APS1 patients (17). …”
Section: Introductionmentioning
confidence: 99%